tiprankstipranks
Immunome, Inc. (IMNM)
NASDAQ:IMNM
US Market
Want to see IMNM full AI Analyst Report?

Immunome (IMNM) Ownership - Who Owns Immunome?

463 Followers

Immunome (IMNM) Ownership Overview

1.51%36.50%5.41%13.23%43.35%
5.41% Other Institutional Investors
13.23% ETFs
43.35% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 55.14% of the company’s stock is owned by Institutional Investors, 1.51% is owned by Insiders, and 43.35% is owned by Public Companies and Individual Investors.
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 41.91% of the company’s stock is owned by Institutional Investors, 1.51% is owned by Insiders, and 13.23% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 09, 2026
xxxxxxxxxxxxx
$204260
Jun 09, 2026
xxxxxxxxxxxxx
$203820
May 19, 2026
xxxxxxxxxxxxx
$103500
Mar 31, 2026
xxxxxxxxxxxxx
$500602

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,047,618Institution6.22%186,198,068
5,764,704Institution5.09%152,303,480
5,501,426Institution4.86%145,347,675
4,788,231Institution4.23%126,505,063
4,322,458Institution3.82%114,199,340
4,320,518Institution3.82%114,148,086
4,099,901Institution3.62%108,319,384
3,867,541Institution3.42%102,180,433
3,411,552Institution3.01%90,133,204
3,117,210Institution2.75%82,356,688

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,047,618Institution6.22%186,198,068
5,764,704Institution5.09%152,303,480
4,322,458Institution3.82%114,199,340
3,867,541Institution3.42%102,180,433
3,117,210Institution2.75%82,356,688
2,776,580Institution2.45%73,357,244
2,178,490Institution1.92%57,555,706
1,665,614Institution1.47%44,005,522
1,617,893Institution1.43%42,744,733
1,103,263Institution0.97%29,148,208

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,225,694Institution2.84%68,352,456
3,015,549Institution2.66%84,405,217
2,698,139Institution2.38%75,520,911
1,223,884Institution1.08%25,934,102
958,345Institution0.84%26,824,077
606,588Institution0.53%12,853,600
507,853Institution0.45%14,214,805
272,423Institution0.24%5,772,643
227,174Institution0.20%6,358,600
201,889Institution0.18%5,650,873

FAQ

Who Owns Immunome, Inc. (IMNM)?
According to the latest TipRanks data, approximately 5.41% of the company's stock is held by institutional investors, 1.51% is held by insiders, and 43.35% is held by retail investors.
    What percentage of Immunome, Inc. (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 5.41% of Immunome, Inc. (IMNM) stock is held by institutional investors.
      What percentage of Immunome, Inc. (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 43.35% of Immunome, Inc. (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome, Inc. (IMNM)?
        Fidelity Mt. Vernon Street Trust owns the most shares of Immunome, Inc. (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.